Neovasc (NSDQ:NVCN) said late yesterday that it resolved the last remaining patent litigation between it and Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies by adding members of CardiAQ as co-inventors of the patents in dispute. Vancouver-based Neovasc said that it added CardiAQ’s Jeremy Brent Ratz and Arshad Quadri as co-inventors of three patents, each of which was related […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
UPDATE: Jury finds J&J’s Ethicon not liable in Philly pelvic mesh trial
UPDATE: Includes comment from J&J’s Ethicon Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon has been found not liable in a suit claiming that an allegedly faulty pelvic mesh implant had caused a patient’s condition to worsen, alongside other complications, according to a report from TheLawFirm.com. A jury in Philadelphia yesterday took less than a full day of deliberations […]
Aidoc raises $27m for medical image analysis software
Medical imaging tech developer Aidoc said this week that it raised $27 million in a Series B round of financing to support its artificial intelligence powered image analysis software. The round was led by Square Peg Capital and will be used to grow the Israel-based company’s tech and go-to-market team. “Our evaluation process included numerous […]
Medline Industries buys Namic business from AngioDynamics
Medline Industries will pay $167.5 million to acquire the Namic fluid management business from AngioDynamics (NSDQ:ANGO), the companies announced today. The deal, subject to customary closing conditions, is expected to close in the summer. It will allow Medline to acquire the manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers and interventional accessories offered […]
Smith & Nephew closes Osiris Therapeutics, Leaf Healthcare buys
Smith & Nephew (NYSE:SNN) said today that it closed both its $660 million acquisition of Osiris Therapeutics (NSDQ:OSIR) and its purchase of Leaf Healthcare and its Leaf Patient Monitoring System. The London-based company said that it paid $19 per share in cash for Osiris, which develops and produces regenerative medicine products including skin, bone grafts and articular […]
Neovasc gains on Reducer study
Shares of Neovasc (NSDQ:NVCN) are up today after the medical device company released study results showing that its Reducer device for treating angina doesn’t worsen heart function and may in fact help. The Vancouver-based company said the 24-patient study of patients treated with Reducer, which is designed to narrow the coronary sinus, showed no significant […]
Miach Orthopaedics fills quality, clinical roles | Personnel Moves, April 17, 2019
Miach Orthopaedics said today that it tapped a pair of executives to oversee the quality systems and clinical program for the knee ligament repair device it’s developing. Miach is working on bio-engineered implants for surgical connective tissue repair, aiming first at anterior cruciate ligament repair with its Bridge-Enhanced ACL Repair device, a sponge that’s designed […]
FDA’s pelvic mesh ban spooks investors
The FDA’s ban on U.S. sales of pelvic mesh products for pelvic organ prolapse may have spooked investors, but should only have a minimal effect on the books at Boston Scientific (NYSE:BSX) and Coloplast (CPH:COLO-B) – the only companies still selling mesh for prolapse in the U.S. – according to analysts and the company. Yesterday the […]
Abbott’s Q1 tops estimates
Abbott (NYSE:ABT) beat the consensus forecast today for both its bottom and top lines during the first quarter. The Chicago-area healthcare giant posted profits of $682.0 million, or 38¢ per share, on sales of $7.54 billion for the three months ended March 31, for a bottom-line gain of 60.8% on sales growth of 2.0% compared […]
Brainsway prices downsized $28m IPO
Brainsway yesterday priced its initial public offering in the U.S. slightly below the terms it set earlier this month. The Jerusalem-based company, which is already publicly traded in Israel, said April 3 that it planned to float 2.5 million American Depository shares at roughly $11.94 apiece. Each ADS is would represent two ordinary shares, slated […]
In2Bones launches CLearGuide LE soft tissue release system
Orthopedic surgical device developer In2Bones said today it launched its ClearGuide LE endoscopic soft tissue release system designed for use by orthopedic and podiatric surgeons to correct foot conditions. The Memphis, Tenn.-based company said that the newly launched system is designed for a variety of soft tissue releases of the lower extremity including plantar fascia, […]